progression of Alzheimer's disease (AD), but the underlying causal mechanisms remain
unclear. A study now provides experimental evidence that hearing loss can promote AD via
the growth differentiation factor 1 (GDF1) pathway, which may aid in developing potential AD
therapeutic strategies.